Kevin S. Emerick, M.D.

Harvard Medical School

Assistant Professor of Otolaryngology
Associate Program Director, Harvard Otolaryngology Residency Program

Massachusetts Eye and Ear

Assistant Scientist

Research Summary

Research Area Affiliations

Research Summary

Dr. Emerick’s primary research interests include the prognostic impact of clinicopathologic features in head and neck cancer. His work has led to the creation of a head and neck cancer calculator, a web-based application that allows users to accurately predict survival data for head and neck cancer patients. This research has allowed for better quantification of the specific risks attributable to unique patient and tumor related features that impact survival.

A second area of interest is high-risk cutaneous malignancies of the head and neck. Particular focus is on defining high-risk features for squamous cell carcinoma and the role of sentinel lymph node biopsy to identify early metastasis. This includes a prospective clinical trial designed to determine the ability of sentinel node biopsy to detect occult metastasis for squamous cell carcinoma. Current research also includes defining clinical and biological behavior for squamous cell carcinoma in the immuncompromised population. Dr. Emerick is currently examining differences in the outcome of immunocompromised patients with metastatic squamous cell carcinoma compared to immunocompetent patients. Lastly, he is developing new techniques for margin analysis in this high-risk population.

The last area of interest is in the development of the supraclavicular flap. Dr. Emerick was the first to perform this flap at Massachusetts Eye and Ear Infirmary, and he currently studies this reconstructive technique. He just completed the only study to date to examine the donor site morbidity of this flap. Ongoing investigation includes defining the utility of the flap in comparison to free tissue transfer.

Select Publications

Clinical presentation, management, and outcome of high-grade mucoepidermoid carcinoma of the parotid gland. Emerick KS, Fabian RL, Deschler DG.  Otolaryngol Head Neck Surg. 2007 May;136(5):783-7.

Primary versus secondary tracheoesophageal puncture in salvage total laryngectomy following chemoradiation.
Emerick KS, Tomycz L, Bradford CR, Lyden TH, Chepeha DB, Wolf GT, Teknos TN. Otolaryngol Head Neck Surg. 2009 Mar;140(3):386-90

Initial Clinical Findings of a Mathematical Model to Predict Survival of Head and Neck Cancer. Emerick KS, Leavitt ER, Michaelson JS, Diephuis B, Clark JR, Deschler DG. Otolaryngol Head Neck Surg. 2013 Jun 24. [Epub ahead of print]

View a complete list of publications on Google Scholar »

View a complete list of publications on pubmed.gov »

Biosketch

Education

B.S. Chemistry, Butler University, 1997
M.D., Indiana University School of Medicine, 2001

Postgraduate Training

Internship in General Surgery, Beth Israel Deaconess Medical Center, 2002
Residency in Otolaryngology–Head and Neck Surgery, Massachusetts Eye and Ear Infirmary/Harvard Medical School, 2006
Fellowship, Head and Neck Oncology and Reconstruction, University of Michigan, 2007

Professional Memberships

American Academy of Otolaryngology – Head and Neck Surgery
American Head and Neck Society
Society of University Otolaryngologists

Awards and Honors

2011: Schwartz Center Compassionate Caregiver Recognition    Schwartz Center for Compassionate Care   
2013: HMS Leadership Development Program for Physicians and Scientists    Harvard Medical School   

Teaching

2012 - present: Associate Program Director, Harvard Otolaryngology Residency Program
2008, 2010, 2012: Advanced Cutaneous Malignancy and Reconstruction, Head and Neck Cancer Update, Harvard Medical School    
2010: Head and Neck Melanoma Update on Management, Head and Neck Cancer Update, Harvard Medical School    
2011: Update on Tracheo-Esopophageal Voice Restoration and Laryngectomy Care, Harvard Medical School:
1. Surgical reconstruction following laryngectomy – functional outcomes and considerations
2. Medical and surgical complications in TEP voice restoration
3. Multidisciplinary treatment of TEP complications
2011: Thyroid Cancer, Surgery of the Thyroid and Parathyroid Glands, Harvard Medical School   
2011: Emergent Airway Surgical Intervention, Emergent Airway Training for Anesthesiologists, Massachusetts Eye and Ear Infirmary    
2012: Atypical and High Risk Cutaneous Malignancy, Head and Neck Cancer Update, Harvard Medical School    
2012: Maine Otolaryngology Society  
1. Atypical and High Risk Cutaneous Malignancy
2. Head and Neck Reconstruction in 2012
2012:
1. Surgical reconstruction following laryngectomy
2. Medical and surgical complications in TEP voice restoration
2012: Update on Tracheo-Esopophageal Voice Restoration and Laryngectomy Care, Stanford University    
2013: Surgical reconstruction following laryngectomy – functional outcomes and considerations, Update on Tracheo-Esopophageal Voice Restoration and Laryngectomy Care, Harvard Medical School    
2013: High Risk Cutaneous Malignancy in the Head and Neck, San Diego Academy of Otolaryngology